Enhancement of transient erythropoietin protein expression by valproic acid in CHO‐K1 suspension adapted cells

Enhancement of transient erythropoietin protein expression by valproic acid in CHO‐K1 suspension adapted cells

Erythropoietin (EPO) is a therapeutic protein that is widely used to increase red blood cell production in chronic kidney failure. EPO protein can be produced quickly with a transient gene expression system (TGE). However, the titer produced using TGE is usually lower than the stable gene expression...

Full description

Bibliographic Details
Main Authors:	Yana Rubiyana, Retno Damajanti Soejoedono, Adi Santoso
Format:	Article
Language:	English
Published:	Universitas Gadjah Mada, Yogyakarta 2020-06-01
Series:	Indonesian Journal of Biotechnology
Subjects:	cho‐k1 erythropoietin (epo) transient gene expression system (tge) histone deacetylase inhibitor (ihdac) val‐ proic acid (vpa)
Online Access:	https://jurnal.ugm.ac.id/ijbiotech/article/view/52621

Similar Items

Mathematical model for the application of Metabolic Flux Analysis to CHO cells producing recombinant human erythropoietin
by: Osmán Fernández, et al.

Comparison of Immobilized Metal Affinity Chromatography Ni-NTA and Co-TALON for the Purification of Recombinant Human Erythropoietin
by: Yana Rubiyana, et al.
Published: (2015-12-01)

The Role of Erythropoietin in Preventing Anemia in the Premature Neonate
by: Oana Cristina Costescu, et al.
Published: (2023-11-01)

Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
by: Anna Thawanny Gadelha Moura, et al.

Stability of erythropoietin repackaging in polypropylene syringes for clinical use
by: Angela Marsili, et al.
Published: (2017-02-01)

Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01)

EXPRESSION OF MODIFIED RECOMBINANT HUMAN ERYTHROPOIETIN IN CHO-K1 CELLS AND ITS IN VITRO PROLIFERATION ASSAY IN TF-1 CELLS
by: Adi Santoso, et al.
Published: (2014-01-01)

Recombinant Human Erythropoietin Production in Chinese Hamster Ovary Cells Is Enhanced by Supplementation of α-Helix Domain of 30Kc19 Protein
by: Hyeonjin Cha, et al.
Published: (2021-11-01)

Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01)

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours
by: Gonçalo dos Santos Clemente, et al.
Published: (2011-03-01)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
by: Yasunori Iwata, et al.
Published: (2021-05-01)

The effects of topical erythropoietin on non-surgical treatment of periodontitis: a preliminary study
by: Hoori Aslroosta, et al.
Published: (2021-05-01)

Valproic Acid and Sleep Duration in Children with Epilepsy
by: J Gordon Millichap
Published: (2009-09-01)

PRECLINICAL STUDIES ON PLEIOTROPIC FUNCTIONS OF ERYTHROPOIETIN ON BONE HEALING
by: R. Vasileva, et al.
Published: (2021-03-01)

Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013-04-01)

Successful treatment of severe anemia using erythropoietin in a Jehovah Witness with non-Hodgkin lymphoma
by: Alexandra Agapidou, et al.
Published: (2014-12-01)

Effectivity of Erythropoietin-Alpha between Fixed- and Adjusted-Dose in Chronic Kidney Disease Patients With Anemia on Hemodialysis
by: Mida Purwiningtyas, et al.
Published: (2021-01-01)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
by: Kausar Humera, et al.
Published: (2011-11-01)

Renal erythropoietin-producing cells in health and disease
by: Tomokazu eSouma, et al.
Published: (2015-06-01)

Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
by: Michelangela Barbieri, et al.
Published: (2024-05-01)

The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus
by: Martha Catalina Rivera-Cervantes, et al.
Published: (2019-02-01)

The utility of testing erythropoietin level in polycythemia diagnosis
by: Abdellatif Ismail, et al.
Published: (2023-12-01)

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
by: Rongliang Wang, et al.
Published: (2016-01-01)

SELECTION OF pEGFP-c1-TRANSFECTED-CHO-K1 CELLS BY G418 DECREASED THE EXPRESSION OF GREEN FLUORESCENT PROTEIN
by: Endah Puji Septisetyani, et al.
Published: (2013-04-01)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2022-08-01)

Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases
by: Miaomiao Zhang, et al.
Published: (2024-01-01)

Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model
by: Guillaume Sarrabayrouse, et al.
Published: (2025-01-01)

Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial
by: Mabel Aoun, et al.
Published: (2022-03-01)

Intermittent Hypoxia Exposure Can Prevent Reductions in Hemoglobin Concentration After Intense Exercise Training in Rats
by: Xiquan Weng, et al.
Published: (2021-02-01)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
by: Zhimin Chen, et al.
Published: (2018-07-01)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
by: Federica Rey, et al.
Published: (2021-01-01)

A Randomized Controlled Trial: Regenerative Effects, Efficacy and Safety of Erythropoietin in Burn and Scalding Injuries
by: Christina I. Günter, et al.
Published: (2018-10-01)

Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning
by: Jolanta Wilimowska, et al.
Published: (2015-03-01)

Valproic acid counteracts polycyclic aromatic hydrocarbons (PAHs)-induced tumorigenic effects by regulating the polarization of macrophages
by: Yisha Zhang, et al.
Published: (2022-08-01)

Erythropoietin as candidate for supportive treatment of severe COVID-19
by: Hannelore Ehrenreich, et al.
Published: (2020-06-01)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
by: Felix Marius Bläsius, et al.
Published: (2023-01-01)

Optimization of amino acid-stabilized erythropoietin parenteral formulation: In vitro and in vivo assessment
by: Fayed Bahgat E., et al.
Published: (2016-03-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

The Role of HDACs as Leukemia Therapy Targets using HDI
by: Ahmad Ahmadzadeh, et al.
Published: (2016-02-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)